Multicenter prospective cohort study to reveal the incidence and risk factors of venous thromboembolism in Japanese patients with IBD.
- Conditions
- Inflammatory Bowel Disease
- Registration Number
- JPRN-UMIN000030524
- Lead Sponsor
- Asahikawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Not provided
1. IBD patients to whom steroids, immunomodulators and biologics need to be administrated for the treatments of disease other than IBD and IBD-related manifestation. 2. Patients who need to receive intensive care for severe complications such as cardiovascular disorder (heart failure, acute coronary syndrome and so on) and pulmonary disorder (respiratory failure, severe pneumonia, bronchial asthma intussusception and so on). 3. Patients with restrictions on their activities, who have malignant tumor with distant metastasis, severe organ failure or are in a terminal state. 4. Patients who are not confirmed to have a diagnosis of IBD, such as IBD unclassified. 5. Patients who do not agree to participate in this study regardless of having received an explanation and consent forms.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of venous thromboembolism in inpatients with IBD.
- Secondary Outcome Measures
Name Time Method 1. Risk of onset for VTE in IBD compared with that in other digestive diseases 2. The site of VTE development, treatment for VTE, outcome of VTE 3. The risk factors of VTE in IBD